Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1897-4287

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance ; volume:10 ; number:2 ; day:12 ; month:4 ; year:2012 ; pages:1-2 ; date:12.2012
Hereditary cancer in clinical practice ; 10, Heft 2 (12.4.2012), 1-2, 12.2012

Contributor: Parsons, M.
Thompson, B.
Goldgar, D.
Hopper, J.
Jenkins, M.
Buchanan, D.
Young, J.
Spurdle, A.
SpringerLink (Online service)

DOI: 10.1186/1897-4287-10-S2-A75

URN: urn:nbn:de:1111-2016073116886

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Parsons, M.
Thompson, B.
Goldgar, D.
Hopper, J.
Jenkins, M.
Buchanan, D.
Young, J.
Spurdle, A.
SpringerLink (Online service)

Other Objects (12)

MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF V600E mutation

Hochschulschrift

Entwicklung eines komplexen NGS-Panels für das kolorektale Karzinom zur parallelen Diagnosik auf Mikrosatelliteninstabilität, MLH1 Promotorhypermethylierung und BRAF V600E Mutation

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young

Hochschulschrift

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF V600E mutation

Hochschulschrift

Entwicklung eines komplexen NGS-Panels für das kolorektale Karzinom zur parallelen Diagnosik auf Mikrosatelliteninstabilität, MLH1 Promotorhypermethylierung und BRAF V600E Mutation

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young

Hochschulschrift

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF V600E mutation

Hochschulschrift

Entwicklung eines komplexen NGS-Panels für das kolorektale Karzinom zur parallelen Diagnosik auf Mikrosatelliteninstabilität, MLH1 Promotorhypermethylierung und BRAF V600E Mutation

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young

Hochschulschrift

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF V600E mutation

Entwicklung eines komplexen NGS-Panels für das kolorektale Karzinom zur parallelen Diagnosik auf Mikrosatelliteninstabilität, MLH1 Promotorhypermethylierung und BRAF V600E Mutation

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF V600E mutation

Entwicklung eines komplexen NGS-Panels für das kolorektale Karzinom zur parallelen Diagnosik auf Mikrosatelliteninstabilität, MLH1 Promotorhypermethylierung und BRAF V600E Mutation

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF V600E mutation

Entwicklung eines komplexen NGS-Panels für das kolorektale Karzinom zur parallelen Diagnosik auf Mikrosatelliteninstabilität, MLH1 Promotorhypermethylierung und BRAF V600E Mutation

Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated

BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young

Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie

Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis

BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature

BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer

Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer

Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms

Related objects

Reset password